❭ Projects ❭ Helse Sør-Øst ❭

Helse Sør-Øst Combination therapy with bortezomib, nanoparticles and radiation against cancer and neurodegenerative diseases

Project duration 2010-2014

Funding Agency: Helse Sør-Øst (South-Eastern Norway Regional Health Authority)

Project number: 2010068
Status: Ongoing
Project reports
2014
2013
2012
2011
2010
 
Feb 21, 2013
Scroll to top

Home Juzenas

  • Group members
  • Projects
    • EuroNanoMed 2015
    • EuroNanoMed 2013
    • NANO2021
    • Helse Sør-Øst
    • NANOMAT
    • R&D
    • For students
  • Collaborations
  • Vacant positions
  • Publications
  • NanoMedLab

Recent publications

Liukaityte R, Stenberg VY, Kleinauskas A, Juzenas P, Urbanucci A, Juzeniene A (2025)
Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models
Med Oncol, 42 (8), 362
DOI 10.1007/s12032-025-02925-9, PubMed 40694184

Espeland K, Christensen E, Aandahl A, Ulvær A, Warloe T, Kleinauskas A, Darvekar S, Juzenas P, Vasovic V, Peng Q, Jahnsen J (2024)
Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn's Disease-A First-in-Human Phase I/II Study
J Clin Med, 13 (20)
DOI 10.3390/jcm13206198, PubMed 39458148

Christensen E, Foss OA, Holien T, Juzenas P, Peng Q (2024)
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study
Pharmaceutics, 16 (6)
DOI 10.3390/pharmaceutics16060815, PubMed 38931936



More publications